CD8+CCR4+ T cells (Tc2 cells; P = 0.017) and the ratio of CD4+CCR5+/CD4+CCR4+ indicating Th1/Th2 (P = 0.041) tended to be lower in MS patients than in HC (Table 2). This evidence concerns the gene CCR5 and myeloid sarcoma.